Navigation Links
Dyadic International Reports Second Quarter 2013 Financial Results
Date:8/8/2013

JUPITER, Fla., Aug. 8, 2013 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global leader in the commercial application of biotechnology for the discovery, development and production of enzymes and other proteins, today announced financial results for the quarter ended June 30, 2013.

(Logo:  http://photos.prnewswire.com/prnh/20110621/CL06708LOGO )

Dyadic's President and Chief Executive Officer, Mark Emalfarb, stated, "The second quarter represented yet another milestone in the emergence of Dyadic as a world leader in the economically and scientifically important business of industrial biotechnology.  Adding to our already world-class stable of partners such as Sanofi and Abengoa, we signed a major license with German chemical giant BASF.  The BASF deal further validates the effectiveness and value of our C1 production technology for commercializing enzymes and other proteins."

Operating HighlightsDuring the quarter, Dyadic announced that it entered into a non-exclusive worldwide license agreement with BASF, the world's leading chemical company with over $90 billion in annual sales.  Under the terms of the agreement, BASF will be able to use Dyadic's patented C1 platform technology to develop, produce, distribute, and sell industrial enzymes in certain fields for a variety of applications.  Additionally, BASF will fund research and development at Dyadic's research lab in The Netherlands.  In addition to this research funding, BASF has agreed to pay Dyadic a $6.0 million upfront license fee, and certain research and commercial milestone fees, as well as royalties upon commercialization.  During the quarter, $4.2 million of the $5.0 million first installment was received, contributing to a significant increase in cash on hand.  The balance of the $1.8 million cash, consisting of a $1.0 million second installment
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Dyadic International To Present At World Biotechnology Congress 2013 And BIO World Congress On Industrial Biotech
2. Dyadic International Reports First Quarter 2013 Financial Results
3. Dyadic International To Announce First Quarter 2013 Financial Results And Host Conference Call On Wednesday, May 15, 2013
4. Danai Brooks Joins Dyadic International as Chief Operating Officer
5. Dyadic International To Speak At Advanced Biofuels Leadership Conference Panel Discussion
6. Dyadic International To Present At World Biofuels Markets
7. Dyadic International To Announce Year-End 2012 Financial Results And Host Conference Call On Thursday, March 7, 2013
8. Dyadic International Upgraded By OTC Markets To "Current Information" Tier
9. 12th U.S. Patent Issued To Dyadic International
10. Dyadic International Reports 2012 Third Quarter Financial Results
11. Dyadic Netherlands To Develop Baking Enzymes For EU-Funded Research Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... September 16, 2014 CIRTEC Medical Systems’ ... Highley as CEO of CIRTEC. , “I am ... for the Company.” noted Brian Highley. “The company has ... sustaining strong organic growth over the past two years. ... continuing to improve and expand the services Cirtec offers ...
(Date:9/16/2014)... 16, 2014   Synthetic Biologics, Inc. ... anti-infective biologic and drug programs targeting specific pathogens ... completion of the Company,s Investor Day in ... irritable bowel syndrome (IBS) program, including its novel, ... In the keynote presentation, Mark Pimentel ...
(Date:9/16/2014)... Arizona (PRWEB) September 16, 2014 ... develops safe and effective products to treat patients ... use of a proprietary SPACE™ Technology Platform announced ... and President will present at the White Hat ... at the Hyatt Regency Phoenix. In addition, ...
(Date:9/16/2014)... BARBARA, Calif. , Sept. 16, 2014 /PRNewswire-iReach/ ... Strength index (BMSi) test identifies patients with bone ... cannot.  Over 160 million people worldwide are at ... detected by today,s standard bone strength test, the ... the 2014 American Society for Bone and Mineral ...
Breaking Biology Technology:Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 2Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 3Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 3ActiveLife's BMSi Test Provides Hope for 160 Million with Undetectable Risk of Bone Fracture 2ActiveLife's BMSi Test Provides Hope for 160 Million with Undetectable Risk of Bone Fracture 3
... Jan. 4 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) ... Annual,JPMorgan Healthcare Conference on Thursday, January 10, 2008 at ... held at the Westin St. Francis,Hotel in San Francisco., ... of Anadys,Pharmaceuticals, Inc., will present an update and overview ...
... 4 ARCA Discovery Inc., a privately held,biopharmaceutical ... other cardiovascular diseases, today announced Richard B.,Brewer, President ... 26th,Annual JPMorgan Healthcare Conference on Tuesday, January 8 ... Conference will be held January 7-10, 2008 at,the ...
... NEW YORK, Jan. 4 QED International ... a series of,20 underlying fund portfolios, today ... on Monday January 7, 2008, Alexion Pharmaceutical, ... Pharmaceutical, Inc. (Nasdaq: ASPV ) in,the ...
Cached Biology Technology:Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference 2ARCA Discovery, Inc. to Present at 26th Annual JPMorgan Healthcare Conference on January 8, 2008 2QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction 2
(Date:9/16/2014)... tree species has its own bacterial identity. That,s the ... other institutions who studied the genetic fingerprints of bacteria ... island. , "This study demonstrates for the first time ... different ecological strategies possess very different microbial communities on ... former postdoctoral researcher in the UO,s Institute of Ecology ...
(Date:9/16/2014)... A complex web of interaction between viruses, bacteria, ... by a growing international collaboration between Matthew Sullivan, ... of Ecology and Evolutionary Biology and Steven Hallam ... Canada. , "Bacteria are drivers of nutrient ... said. "As the climate is changing, so are ...
(Date:9/16/2014)... extravagant, colorful tail feathers in courtship of a peahen. ... camera developed by an engineer at Washington University in ... choose their mates based on a similar display. , ... used a bioinspired polarization camera developed by Viktor Gruev, ... Washington University, to make the discovery. His camera has ...
Breaking Biology News(10 mins):Microbiome research shows each tree species has a unique bacterial identity 2New research decodes virus-host interactions in ocean dead zones 2New research decodes virus-host interactions in ocean dead zones 3Camera developed at WUSTL sheds light on mate choice of swordtail fish 2
... Nov. 9, 2007 Researchers at Childrens Hospital of ... currently underway to study the effectiveness of oral insulin in ... people at risk for the disease. The researchers want ... or delay the onset of type 1 diabetes in relatives ...
... Flip through the 133 page record of the 2006-2007 activities ... and youll see why they recently took home the nations ... toss fundraiser. Youll find the detailed lesson plans that ... to 75 fifth grades at Spreckels elementary school last year. ...
... helping an effort to eradicate malaria, the mosquito-borne disease ... Researchers at the National Institute of Standards and Technology ... a young company create weakened, harmless versions of the ... to create a new type of vaccine that shows ...
Cached Biology News:Children's Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes 2UC-San Diego Engineering Honor Society wins most outstanding chapter award 2Bug-Zapper: A dose of radiation may help knock out malaria 2
... The Label IT siRNA Tracker Intracellular ... to directly label and deliver siRNA, of ... manner, for in vitro tracking experiments. Subcellular ... expression can be monitored following introduction of ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ID ...
... through the extracellular matrix (ECM) is an ... cells initiate invasion by adhering to and ... Proteolytic enzymes, such as MMP collagenases, dissolve ... membrane) surrounding the blood vessels to allow ...
... Cell Invasion Assay is designed to determine ... as a significant barrier to invasion or ... in a convenient, high-throughput, 96-well format. The ... all types of adherent cells such as ...
Biology Products: